Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1999-11-09
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544118, 544271, 544272, 544267, A61K 3152, C07D47306
Patent
active
059815353
ABSTRACT:
A method for the treatment of cerebrovascular disorders and/or disorders associated with cerebral senility and/or allergic disorders, proliferative skin disorders, and bronchodilation which method comprises the administration of an effective, non-toxic amount of a compound of formula (I): ##STR1## or if appropriate a pharmaceutically acceptable salt thereof, wherein R.sup.1 and R.sup.2 each independently represent alkyl or a moiety of formula (a):
REFERENCES:
patent: 757328 (1904-04-01), Ach
patent: 2517410 (1950-08-01), Papesch
patent: 4120947 (1978-10-01), Diamond
patent: 4450163 (1984-05-01), Philippossian
patent: 4544556 (1985-10-01), Fedi et al.
patent: 4593095 (1986-06-01), Snyder et al.
patent: 4704381 (1987-11-01), Schaumann et al.
patent: 4868186 (1989-09-01), Franzone et al.
Wells, et al., "Inhibition of Separated Forms . . . ", J. Med. Chem., 81; vol. 24 (8) pp. 954-958, 1977.
Smellie, et al., "Alkylxanthines . . . ", NIH, Natl. Inst. Arthritis. Metab. Dig. Dis., Bethesda Md., 1979.
Kramer, et al., "Selective Inhibition . . . ", Biochemistry 77, vol. 16 (15) pp. 3316-3321, 1977.
J.A. Beavo et al, Molecular Pharmacology, 6, (1970), pp. 597-603.
Annalen der Chemie, 47, (1957) pp. 362-365.
K.H. Klinger, Drug Research 27(1), No. 19, (1977) pp. 4-14.
R.G. Werner et al, Drug Res., 31(II), No. 12 (1981) pp. 2044-2048.
Bickenbach, Differentiation 61, 129, 1996.
Maschler Harald
Smith Harry
Spicer Barbara Ann
Berch Mark L.
Dinner Dara L.
Kinzig Charles M.
SmithKline Beecham p.l.c.
Venetianer Stephen
LandOfFree
Substituted xanthines and their use in the treatment of cerebrov does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted xanthines and their use in the treatment of cerebrov, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted xanthines and their use in the treatment of cerebrov will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456351